A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.

Dhindsa RS, Zoghbi AW, Krizay DK, Vasavda C, Goldstein DB

DOI: 10.1002/ana.25950
Published: 2021 Feb
Container: Annals of neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ana.25950,
  title = {A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.},
  author = {Dhindsa RS and Zoghbi AW and Krizay DK and Vasavda C and Goldstein DB},
  year = {2021},
  journal = {Annals of neurology},
  doi = {10.1002/ana.25950},
  url = {https://doi.org/10.1002/ana.25950}
}

RIS

TY  - JOUR
TI  - A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.
AU  - Dhindsa RS
AU  - Zoghbi AW
AU  - Krizay DK
AU  - Vasavda C
AU  - Goldstein DB
PY  - 2021
JO  - Annals of neurology
DO  - 10.1002/ana.25950
UR  - https://doi.org/10.1002/ana.25950
ER  -

APA

RS, D., AW, Z., DK, K., C, V., & DB, G. (2021). A Transcriptome-Based Drug Discovery Paradigm for Neurodevelopmental Disorders.. Annals of neurology. https://doi.org/10.1002/ana.25950

Source records

pubmed · retrieved 2026-09-25T20:15:56.422Z
europe-pmc · retrieved 2026-09-25T20:15:56.442Z